Mahindra said engineering teams from the company's Mumbai (Kandivali) and Nashik (Igatpuri) plants developed the ‘game changing’ device in two days
Automajor Mahindra & Mahindra (M&M) will manufacture in-house 'ambu bag' ventilators for less than Rs 7,500, Group Chairman Anand Mahindra stated.
In a tweet on March 26, the industrialist said that engineering teams from the company's Mumbai (Kandivali) and Nashik (Igatpuri) plants developed the 'game changing' device in two days.
Ambu bags -- or artificial breathing unit bags -- are a prototype bag valve mask with self-inflating mechanism, which aid a patient in breathing, M&M Managing Director Pawan Goenka explained.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
As @GoenkaPk tweeted, we are simultaneously working with an indigenous maker of ICU ventilators. These are sophisticated machines costing between 5 to 10 lakhs. This device is an interim lifesaver & the team estimates it will cost below ₹7,500 https://t.co/3rz1FBkPF0
— anand mahindra (@anandmahindra) March 26, 2020
Earlier on March 26, Goenka had tweeted that the company was working on an automated version of the Bag Valve Mask ventilator, commonly known as Ambu bag.
Ventilator 3: at other end we are working on an automated version of the Bag Valve Mask ventilator (commonly known as Ambu bag). We hope to have a Proto ready in 3 days for approval. Once proven this design will be made available to all for manufacturing. @PMOIndia @MahindraRise— Pawan K Goenka (@GoenkaPk) March 26, 2020
On March 22, Mahindra also offered the group's hospitality arm as a medical care facility and said the group will work on how its manufacturing facilities can manufacture ventilators.
"Going by various reports from epidemiologists, it is highly likely that India is already in stage-3 of transmission. Cases could rise exponentially with millions of casualties, putting a huge strain on medical infrastructure," Mahindra said in a series of tweets.Sharing plans of the group which has presence across sectors ranging from farm equipment to aerospace, he said, "To help in the response to this unprecedented threat, we at the Mahindra Group will immediately begin work on how our manufacturing facilities can make ventilators."